tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Heart Failure D006333 36 associated lipids
Angioedema D000799 6 associated lipids
Fractures, Spontaneous D005598 4 associated lipids
Hydronephrosis D006869 4 associated lipids
Trypanosomiasis D014352 5 associated lipids
Alopecia D000505 14 associated lipids
Liver Diseases D008107 31 associated lipids
Corneal Diseases D003316 13 associated lipids
Testicular Diseases D013733 15 associated lipids
Facial Dermatoses D005148 7 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Tanaka E and Yamanaka H [DMARDs (disease-modifying antirheumatic drugs)]. 2013 Nippon Rinsho pmid:23961667
Hou S Pregnancy in renal transplant recipients. 2013 Adv Chronic Kidney Dis pmid:23928390
Uslu Gokceoglu A et al. Hyperuricemia in pediatric renal transplant recipients. 2013 Exp Clin Transplant pmid:24344940
Peddi VR et al. Review of combination therapy with mTOR inhibitors and tacrolimus minimization after transplantation. 2013 Transplant Rev (Orlando) pmid:23932018
Ormaechea-Pérez N et al. Superficial granulomatous pyoderma. Report of 2 cases treated with topical tacrolimus. 2013 Actas Dermosifiliogr pmid:23933249
Konofaos P and Terzis JK FK506 and nerve regeneration: past, present, and future. 2013 J Reconstr Microsurg pmid:23322540
Payne SJ et al. The efficacy of tacrolimus and sirolimus in heavily pre-treated unresectable thymic malignancies. 2013 Lung Cancer pmid:23380223
Bock ME et al. Treatment of childhood nephrotic syndrome with long-term, low-dose tacrolimus. 2013 Clin. Nephrol. pmid:23380387
Andrades KM et al. Modulation of Candida albicans virulence by antirejection immunosuppressant drugs. 2013 Transplantation pmid:23380869
Shilbayeh S et al. The impact of CYP3A5 and MDR1 polymorphisms on tacrolimus dosage requirements and trough concentrations in pediatric renal transplant recipients. 2013 Saudi J Kidney Dis Transpl pmid:24231473
Legris T et al. Humoral immunity after kidney transplantation: impact of two randomized immunosuppressive protocols. 2013 Ann. Transplant. pmid:24231646
Fan JY et al. Noncanonical FK506-binding protein BDBT binds DBT to enhance its circadian function and forms foci at night. 2013 Neuron pmid:24210908
Saeki H [Brief commentary on guidelines for the management of atopic dermatitis 2012 -the point of drug treatment]. 2013 Arerugi pmid:24608647
Herranz M et al. Bioequivalence between generic tacrolimus products marketed in Spain by adjusted indirect comparison. 2013 Eur. J. Clin. Pharmacol. pmid:23196824
Ali MN et al. Case series: hemolytic uremic syndrome--another cause of transplant dysfunction. 2013 Transplant. Proc. pmid:24182801
Michel M et al. Protein phosphatase-dependent circadian regulation of intermediate-term associative memory. 2013 J. Neurosci. pmid:23467376
Grigoriu S et al. The molecular mechanism of substrate engagement and immunosuppressant inhibition of calcineurin. 2013 PLoS Biol. pmid:23468591
Que J et al. Effect of FK506 in reducing scar formation by inducing fibroblast apoptosis after sciatic nerve injury in rats. 2013 Cell Death Dis pmid:23470533
Chen YL et al. Posaconazole exhibits in vitro and in vivo synergistic antifungal activity with caspofungin or FK506 against Candida albicans. 2013 PLoS ONE pmid:23472097
Tsukamoto H et al. Infliximab salvage therapy for patients with ulcerative colitis who failed to respond to tacrolimus. 2013 Eur J Gastroenterol Hepatol pmid:23411870
Naniwa T et al. Case report: successful use of short-term add-on tocilizumab for multirefractory systemic flare of adult-onset Still's disease. 2013 Clin. Rheumatol. pmid:20842515
Breckner A et al. Effect of Calstabin1 depletion on calcium transients and energy utilization in muscle fibers and treatment opportunities with RyR1 stabilizers. 2013 PLoS ONE pmid:24303040
Zhang J et al. Helminth protein vaccine induced follicular T helper cell for enhancement of humoral immunity against Schistosoma japonicum. 2013 Biomed Res Int pmid:24308005
Nakamura T et al. Co-stimulation with bone morphogenetic protein-9 and FK506 induces remarkable osteoblastic differentiation in rat dedifferentiated fat cells. 2013 Biochem. Biophys. Res. Commun. pmid:24064349
Wu G et al. Tacrolimus-induced encephalopathy and polyneuropathy in a renal transplant recipient. 2013 BMJ Case Rep pmid:24311415
Masri M et al. Prograf five milligrams versus Tacrolimus medis in healthy volunteers: a bioequivalence study. 2013 Transplant. Proc. pmid:24314930
Elens L et al. Impact of CYP3A4*22 allele on tacrolimus pharmacokinetics in early period after renal transplantation: toward updated genotype-based dosage guidelines. 2013 Ther Drug Monit pmid:24052064
Gordon S et al. Success using tacrolimus in patients with proliferative and membranous lupus nephritis and refractory proteinuria. 2013 Hawaii J Med Public Health pmid:24052913
Lee SE et al. Differential effects of topical corticosteroid and calcineurin inhibitor on the epidermal tight junction. 2013 Exp. Dermatol. pmid:23174045
Koster RA et al. Fast LC-MS/MS analysis of tacrolimus, sirolimus, everolimus and cyclosporin A in dried blood spots and the influence of the hematocrit and immunosuppressant concentration on recovery. 2013 Talanta pmid:24054560
Sadilkova K et al. Clinical validation and implementation of a multiplexed immunosuppressant assay in dried blood spots by LC-MS/MS. 2013 Clin. Chim. Acta pmid:23473895
Carassiti M and Antonelli S PRES: clinical evidence or incidental finding? 2013 Minerva Anestesiol pmid:23174927
Welberry Smith MP et al. Alemtuzumab induction in renal transplantation permits safe steroid avoidance with tacrolimus monotherapy: a randomized controlled trial. 2013 Transplantation pmid:24056618
Yarur A and Kane SV Update on pregnancy and breastfeeding in the era of biologics. 2013 Dig Liver Dis pmid:23474350
Bosó V et al. Increased hospital stay and allograft dysfunction in renal transplant recipients with Cyp2c19 AA variant in SNP rs4244285. 2013 Drug Metab. Dispos. pmid:23175667
Schnider JT et al. Site-specific immunosuppression in vascularized composite allotransplantation: prospects and potential. 2013 Clin. Dev. Immunol. pmid:23476677
Pereira-Lopes O et al. Periodontal inflammation in renal transplant recipients receiving everolimus or tacrolimus - preliminary results. 2013 Oral Dis pmid:23448098
Bouamar R et al. Tacrolimus predose concentrations do not predict the risk of acute rejection after renal transplantation: a pooled analysis from three randomized-controlled clinical trials(†). 2013 Am. J. Transplant. pmid:23480233
Nirmal J et al. Development of potential orphan drug therapy of intravesical liposomal tacrolimus for hemorrhagic cystitis due to increased local drug exposure. 2013 J. Urol. pmid:23127767
Okada K et al. Vialinin A is a ubiquitin-specific peptidase inhibitor. 2013 Bioorg. Med. Chem. Lett. pmid:23791076
Kanzaki T et al. Long-term therapeutic effects and safety of tacrolimus added to methotrexate in patients with rheumatoid arthritis. 2013 Rheumatol. Int. pmid:22806421
Goldust M et al. Treatment of seborrheic dermatitis: the efficiency of sertaconazole 2% cream vs. tacrolimus 0.03% cream. 2013 Ann Parasitol pmid:24171300
Kato M et al. Pneumocystis pneumonia induced by treatment with low-dose tacrolimus and methylprednisolone in a patient with rheumatoid arthritis: a case report. 2013 BMC Res Notes pmid:24289285
Hillen U et al. Tumor regression and sirolimus-based therapy in lung transplantation. 2013 J. Heart Lung Transplant. pmid:23953823
Watanabe M et al. Efficacy of DHMEQ, a NF-κB inhibitor, in islet transplantation: II. Induction DHMEQ treatment ameliorates subsequent alloimmune responses and permits long-term islet allograft acceptance. 2013 Transplantation pmid:23860082
Annunziato RA et al. Strangers headed to a strange land? A pilot study of using a transition coordinator to improve transfer from pediatric to adult services. 2013 J. Pediatr. pmid:23993138
Kim YC et al. Tacrolimus decreases albuminuria in patients with IgA nephropathy and normal blood pressure: a double-blind randomized controlled trial of efficacy of tacrolimus on IgA nephropathy. 2013 PLoS ONE pmid:23977072
Mok CC et al. Combined low-dose mycophenolate mofetil and tacrolimus for lupus nephritis with suboptimal response to standard therapy: a 12-month prospective study. 2013 Lupus pmid:23995863
Bumbacea RS and Ghiordanescu I Atopic dermatitis induced by systemic immunosupression with tacrolimus--case report. 2013 Eur Ann Allergy Clin Immunol pmid:23862401
Sartori-Valinotti JC et al. A 10-year review of otic lichen planus: the Mayo Clinic experience. 2013 JAMA Dermatol pmid:23824252
Zhang JJ et al. Effect of the P450 oxidoreductase 28 polymorphism on the pharmacokinetics of tacrolimus in Chinese healthy male volunteers. 2013 Eur. J. Clin. Pharmacol. pmid:23097010
Stefos GC et al. NGF upregulates the plasminogen activation inhibitor-1 in neurons via the calcineurin/NFAT pathway and the Down syndrome-related proteins DYRK1A and RCAN1 attenuate this effect. 2013 PLoS ONE pmid:23825664
Elfadawy N et al. The impact of surveillance and rapid reduction in immunosuppression to control BK virus-related graft injury in kidney transplantation. 2013 Transpl. Int. pmid:23763289
Wang NK et al. Origin of fundus hyperautofluorescent spots and their role in retinal degeneration in a mouse model of Goldmann-Favre syndrome. 2013 Dis Model Mech pmid:23828046
Li X et al. Tacrolimus as rescue therapy for adult-onset refractory minimal change nephrotic syndrome with reversible acute renal failure. 2013 Nephrol. Dial. Transplant. pmid:23787554
Onumah N and Kircik L Pimecrolimus cream and Tacrolimus ointment in the treatment of atopic dermatitis: a pilot study on patient preference. 2013 J Drugs Dermatol pmid:24085050
Willems MC et al. Tacrolimus does not affect early wound healing in a rodent model of bowel anastomoses and abdominal wall closure. 2013 PLoS ONE pmid:24086731
Musuamba FT et al. Statistical tools for dose individualization of mycophenolic acid and tacrolimus co-administered during the first month after renal transplantation. 2013 Br J Clin Pharmacol pmid:23072565
Zahn A et al. Mycophenolate mofetil combination therapy improves survival after liver transplantation. A single-center retrospective analysis. 2013 Ann. Transplant. pmid:24088725
Wang Y et al. Increasing the efficiency of ligands for FK506-binding protein 51 by conformational control. 2013 J. Med. Chem. pmid:23647266
Sánchez M et al. Membranous glomerulonephritis in a patient with Hodgkin's lymphoma in remission. 2013 Nefrologia pmid:24089174
Wong VW et al. Tacrolimus fails to regulate collagen expression in dermal fibroblasts. 2013 J. Surg. Res. pmid:23647800
Baradaran-Rafii A et al. Complications of keratolimbal allograft surgery. 2013 Cornea pmid:23073489
Kishi K et al. [Successful effect of tacrolimus in a 5-year-old boy presenting with repeated episodes of non-herpetic acute limbic encephalitis]. 2013 No To Hattatsu pmid:23650823
Rodriguez-Rodriguez AE et al. The higher diabetogenic risk of tacrolimus depends on pre-existing insulin resistance. A study in obese and lean Zucker rats. 2013 Am. J. Transplant. pmid:23651473
Yuan H et al. Effect of prolonged tacrolimus treatment in idiopathic membranous nephropathy with nephrotic syndrome. 2013 Pharmacology pmid:23652322
Tirado-Sánchez A and Ponce-Olivera RM Tacrolimus in confluent and reticulated papillomatosis of Gougerot Carteaud. 2013 Int. J. Dermatol. pmid:22512695
Xu J et al. Tacrolimus combined with corticosteroids in idiopathic membranous nephropathy: a randomized, prospective, controlled trial. 2013 Contrib Nephrol pmid:23689577
Rerknimitr P et al. Topical tacrolimus significantly promotes repigmentation in idiopathic guttate hypomelanosis: a double-blind, randomized, placebo-controlled study. 2013 J Eur Acad Dermatol Venereol pmid:22324720
Goyal RK et al. Sirolimus pharmacokinetics in early postmyeloablative pediatric blood and marrow transplantation. 2013 Biol. Blood Marrow Transplant. pmid:23266742
Hickey MD et al. Use of rifabutin for the treatment of a latent tuberculosis infection in a patient after solid organ transplantation. 2013 Liver Transpl. pmid:23526600
Lee WJ et al. Penile lichen nitidus successfully treated with topical pimecrolimus 1% cream. 2013 J. Dermatol. pmid:23551296
Dähnhardt-Pfeiffer S et al. Comparison of effects of tacrolimus ointment and mometasone furoate cream on the epidermal barrier of patients with atopic dermatitis. 2013 J Dtsch Dermatol Ges pmid:23551950
Cadou A et al. The Kin1 kinase and the calcineurin phosphatase cooperate to link actin ring assembly and septum synthesis in fission yeast. 2013 Biol. Cell pmid:23294323
Barequet IS et al. Topical tacrolimus for the management of acute allergic conjunctivitis in a mouse model. 2013 Graefes Arch. Clin. Exp. Ophthalmol. pmid:23553288
Lin W et al. Oligodendrocyte-specific activation of PERK signaling protects mice against experimental autoimmune encephalomyelitis. 2013 J. Neurosci. pmid:23554479
Niioka T et al. A limited sampling strategy to estimate the area under the concentration-time curve of tacrolimus modified-release once-daily preparation in renal transplant recipients. 2013 Ther Drug Monit pmid:23296097
Najera JE et al. Akinetic mutism-a serious complication to tacrolimus-based GVHD prophylaxis. 2013 Bone Marrow Transplant. pmid:22705799
Zhao W et al. Population pharmacokinetics and pharmacogenetics of once daily prolonged-release formulation of tacrolimus in pediatric and adolescent kidney transplant recipients. 2013 Eur. J. Clin. Pharmacol. pmid:22706623
Supavekin S et al. Tacrolimus in steroid resistant and steroid dependent childhood nephrotic syndrome. 2013 J Med Assoc Thai pmid:23720975
Sahay S et al. Calcineurin-inhibitor induced pain syndrome in a lung transplant patient. 2013 Transpl. Int. pmid:23590753
Moore LW Food, food components, and botanicals affecting drug metabolism in transplantation. 2013 J Ren Nutr pmid:23611558
Penninga L et al. Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients. 2013 Cochrane Database Syst Rev pmid:23728681
Caplan AL Ensuring the future of uterine transplantation. 2013 Fertil. Steril. pmid:23200690
Rostaing L et al. Alefacept combined with tacrolimus, mycophenolate mofetil and steroids in de novo kidney transplantation: a randomized controlled trial. 2013 Am. J. Transplant. pmid:23730730
Acquazzino MA et al. Refractory autoimmune hemolytic anemia after intestinal transplant responding to conversion from a calcineurin to mTOR inhibitor. 2013 Pediatr Transplant pmid:23730873
Kim HY et al. The imbalance of T helper 17/regulatory T cells and memory B cells during the early post-transplantation period in peripheral blood of living donor liver transplantation recipients under calcineurin inhibitor-based immunosuppression. 2013 Immunology pmid:23205589
Ramos E et al. Post-transplant lymphoproliferative disorders and other malignancies after pediatric intestinal transplantation: incidence, clinical features and outcome. 2013 Pediatr Transplant pmid:23730927
Zhao W et al. Limited sampling strategy using Bayesian estimation for estimating individual exposure of the once-daily prolonged-release formulation of tacrolimus in kidney transplant children. 2013 Eur. J. Clin. Pharmacol. pmid:23208323
Tavira B et al. A search for new CYP3A4 variants as determinants of tacrolimus dose requirements in renal-transplanted patients. 2013 Pharmacogenet. Genomics pmid:23778326
Patsatsi A et al. A therapeutic approach for female, relapsing genital lichen sclerosus: a single-center study. 2013 J Dermatolog Treat pmid:23164046
Bazerbachi F et al. Pancreas-after-kidney versus synchronous pancreas-kidney transplantation: comparison of intermediate-term results. 2013 Transplantation pmid:23183776
Shibasaki S et al. Immunosuppressive effects of DTCM-G, a novel inhibitor of the mTOR downstream signaling pathway. 2013 Transplantation pmid:23269193
Lieber SR and Volk ML Non-adherence and graft failure in adult liver transplant recipients. 2013 Dig. Dis. Sci. pmid:23053889
Kim TW et al. Proactive treatment of adult facial seborrhoeic dermatitis with 0.1% tacrolimus ointment: randomized, double-blind, vehicle-controlled, multi-centre trial. 2013 Acta Derm. Venereol. pmid:23388687
de Sandes-Freitas TV et al. Basiliximab induction in patients receiving tacrolimus-based immunosuppressive regimens. 2013 Int Urol Nephrol pmid:23054318
Tatar E et al. Pre-transplant HbA1c level as an early marker for new-onset diabetes after renal transplantation. 2013 Int Urol Nephrol pmid:23054321
Kim DH et al. Mutational biosynthesis of tacrolimus analogues by fkbO deletion mutant of Streptomyces sp. KCTC 11604BP. 2013 Appl. Microbiol. Biotechnol. pmid:23392766
Lee YJ et al. Application for tacrolimus ointment in treating refractory inflammatory ocular surface diseases. 2013 Am. J. Ophthalmol. pmid:23394907
Boyer O et al. Renal function and histology in children after small bowel transplantation. 2013 Pediatr Transplant pmid:22882667